Abstract
Corrigendum to ''A glucose-targeted mixed micellar formulation outperforms Genexol in breast cancer cells'' [Euro. J. Pharmaceut. Biopharmaceut. 114 (2017) 305-316
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have